222420-83-9

Upstream product

• 69945-44-4 (1RS,2SR,3RS,4RS)-2,3-dibromocyclohex-5-ene-1,4-diol 
• 112212-81-4 (+/-)-(1S,2R,3R,4S)-1,4-diacetoxy-2,3-dibromocyclohex-5-ene 
• 106-51-4 p-benzoquinone 
• 222420-77-1 (1S,2R,3R,4S)-1,4-bis-O-(di-O-benzylphospho)conduritol B 
• 5273-61-0 (5RS,6RS)-5,6-dibromocyclohex-2-ene-1,4-dione 
• 169529-92-4 (+)-(1R,2S,3S,4R)-2,3-dibromocyclohex-5-ene-1,4-diol 
• 864372-82-7 (1S,2S,3S,4S)-1,4-bis-O-(di-O-benzylphospho)-2,3-bis-O-(2-oxo-5,6-benzo-1,3,2-dioxaphosphep-2-yl)conduritol-B 
• 80582-75-8 (1R,2R,3R,4R)-anti-benzene dioxide 

Downstream Products

• 112791-61-4 [3H]-Inositol-3,4,5,6-tetrakisphosphate 

Relevant academic research and scientific papers

Enzyme-assisted total synthesis of the optical antipodes D-myo-inositol 3,4,5-trisphosphate and D-myo-inositol 1,5,6-trisphosphate: Aspects of their structure-activity relationship to biologically active inositol phosphates

Unambiguous total syntheses of both optical antipodes of the enantiomeric pair D-myo-inositol 3,4,5-trisphosphate (Ins(3,4,5)P3) and D- myo-inositol 1,5,6-trisphosphate (Ins(1,5,6)P3) are described. The ring system characteristic of